7971 studies found for:    "Urologic Diseases"
Show Display Options
Rank Status Study
1 Completed Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency
Condition: Urologic Disease
Intervention: Drug: calcium disodium EDTA (edetate calcium disodium)
2 Not yet recruiting Percutaneous Externally-Assembled Laparoscopic Urologic Surgery
Condition: Urologic Diseases
Intervention: Procedure: PEAL surgery
3 Completed Patient-driven Compression in Urography
Condition: Urologic Diseases
Interventions: Device: Patient-regulated compression device;   Device: Standard compression device
4 Recruiting A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
Conditions: Carcinoma, Renal Cell;   Kidney Diseases;   Kidney Neoplasms;   Urogenital Neoplasms;   Urologic Diseases;   Urologic Neoplasms;   Neoplasms by Histologic Type;   Neoplasms;   Clear-cell Metastatic Renal Cell Carcinoma;   Melanoma;   Triple Negative Breast Cancer;   Bladder Cancer;   Head and Neck Cancer;   Non-small Cell Lung Cancer
Intervention: Drug: Combination of Varlilumab and Atezolizumab
5 Recruiting Folic Acid for Prevention of Contrast Induced Nephropathy
Conditions: Kidney Diseases;   Urologic Diseases
Interventions: Drug: Folic acid;   Drug: Placebo
6 Recruiting A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Conditions: Carcinoma, Renal Cell;   Kidney Diseases;   Kidney Neoplasms;   Urogenital Neoplasms;   Urologic Diseases;   Urologic Neoplasms;   Neoplasms;   Neoplasms by Histologic Type;   Clear-cell Metastatic Renal Cell Carcinoma
Intervention: Drug: Combination of varlilumab and sunitinib
7 Recruiting A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
Conditions: Urinary Bladder Overactive;   Overactive Bladder;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: mirabegron;   Drug: antimuscarinic medication
8 Active, not recruiting A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Intervention: Drug: Betmiga®
9 Recruiting Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
Conditions: Urinary Incontinence;   Stress;   Urination Disorders;   Urologic Diseases;   Lower Urinary Tract Symptoms;   Urological Manifestations
Intervention: Biological: autologous muscle-derived cells (AMDC)
10 Withdrawn SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I
Conditions: Urinary Bladder Neoplasms;   Urologic Neoplasms;   Urogenital Neoplasms;   Neoplasms;   Neoplasms by Site;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Device: Synergo + MMC;   Drug: Bacillus Calmette-Guérin
11 Completed Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State
Condition: Urologic Diseases
Interventions: Drug: Commercially available combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg;   Drug: Second generation dutasteride 0.5 mg and tamsulosin HCL 0.4 mg combination capsule
12 Completed Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State
Condition: Urologic Diseases
Interventions: Drug: Commercially available combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg;   Drug: Second generation dutasteride 0.5 mg and tamsulosin HCL 0.4 mg combination capsule
13 Completed A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Conditions: Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: Mirabegron;   Drug: Solifenacin succinate low dose;   Drug: Solifenacin succinate high dose
14 Completed Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Conditions: Urinary Tract Infections;   Infection;   Urologic Diseases
Interventions: Other: cranberry juice;   Other: placebo beverage
15 Recruiting Pelvic Floor Muscles Training in Men Undergoing Radiotherapy for Prostate Cancer: Randomized Controlled Trial
Conditions: Prostate Cancer;   Urologic Diseases
Intervention: Other: Pelvic floor muscles training
16 Completed A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Are Previously Treated With Another Medicine But Were Not Satisfied With That Treatment
Conditions: Urinary Bladder, Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: Mirabegron;   Drug: Solifenacin succinate
17 Completed A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)
Conditions: Cystitis, Interstitial;   Urologic Diseases;   Urinary Bladder Disease;   Pain
Interventions: Drug: ASP3652;   Drug: Placebo
18 Completed Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity
Conditions: Neurogenic Urinary Bladder Disorder;   Urinary Bladder, Neurogenic;   Bladder Disorder, Neurogenic;   Urinary Bladder Disorder, Neurogenic;   Neurogenic Bladder Disorder;   Urinary Bladder Neurogenic Dysfunction;   Urologic Diseases;   Overactive Detrusor Function;   Urinary Incontinence
Interventions: Drug: Propiverine hydrochloride ER (extended release);   Drug: Propiverine hydrochloride IR (immediate release)
19 Recruiting Renal Hypothermia During Partial Nephrectomy
Conditions: Renal Impairment;   Kidney Diseases;   Urologic Diseases;   Cancer;   Hypothermia;   Kidney Cancer
Intervention: Procedure: Renal hypothermia
20 Completed
Has Results
A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder
Conditions: Urinary Bladder, Overactive;   Urinary Bladder Diseases;   Urologic Diseases;   Urological Manifestations;   Signs and Symptoms
Interventions: Drug: Mirabegron;   Drug: Solifenacin succinate;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years